Maps of lung adenocarcinoma cancer in males (A) standardized incidence ratios; (B) stabilized kriged standardized incidence ratios; (C) average annual percent changes; (D) stabilized kriged average annual percent changes). The map was created by R version 3.5.2 with the ggplot2 package (https:...
Leiter Amanda,Veluswamy Rajwanth R,Wisnivesky Juan P,The global burden of lung cancer: current status and future trends.[J] .Nat Rev Clin Oncol, 2023, 20: 624-639. Lung cancer is the leading cause of cancer-related death worldwide. However, lung cancer incidence and mortality rates diff...
doi:10.1097/01.COT.0000998352.07872.3cLindsey NolenWolters Kluwer Health, Inc.Oncology Times
Background Lung cancer is the second most common cancer worldwide, yet the distribution by histological subtype remains unknown. We aimed to quantify the global, regional, and national burden of lung cancer incidence for the four main subtypes in 185 countries and territories.Methods In this popula...
The incidence of new lung cancer has decreased between 1999-2019, mirroring the fall in tobacco use in the past few decades. Lung cancer-related mortality has also decreased with the recent advances in screening techniques and treatment strategies. However, the incidence of lung cancer and lung ...
we cannot assume that epigenetic changes occurring on different neighborhood deprivation levels are limited to the promoter gene regions. Our patient cohort was skewed towards earlier-stage disease compared to the incidence stage of lung cancer in the general population. A greater effect may be seen ...
[6]Huang L, Feng Y, Xie T, et al. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer. BMC Cancer. 2023 Apr 5;23(1):312. ...
Theglobal industrywas valued atUS$ 15.1 Bnin2023 It is projected to grow at aCAGRof7.9%from2024 to 2034and reach more thanUS$ 34.8 Bnby the end of2034 Analysts’ Viewpoint Regarding Lung Cancer Diagnostics Market Increase in incidence of lung cancer, especially in developing countries, is the...
Lung cancer is a malignant tumor of the respiratory system with a high incidence, and it has the highest mortality rate among both men and women, non-small cell lung cancer (NSCLC) accounts for 80% of all lung cancer pathology types, and half of NSCLC is LUAD18. Targeting TME could ass...
2023, Lung Cancer Citation Excerpt : Based on good efficacy and controllable safety, Food and Drug Administration (FDA) approved a dose of 5.4 mg/kg of T-DXd on August 11, 2022 for advanced and metastatic ERBB2-mutant NSCLC patients who had previously received systemic therapy [27]. Now an...